Latest News Israel

Teva buys Merck KGaA women’s health unit

Share |
Thursday, October 28th, 2010

As reported in Globes:

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has acquired Théramex and related companies, the women’s health products division of Germany’s Merck KGaA (DAX: MRK) unit Merck Serono, for €265 million, plus milestone payments.

Teva will fund the acquisition from its internal resources, and expects to close the deal by the end of the year or in early 2011.

Théramex offers a wide variety of women’s health products sold in 50 countries. It had €100 million revenue in 2009, including sales in the countries in which Teva will acquire distribution rights, such as Spain and Brazil. A large part of its revenue is from direct sales in France and Italy.

Read more here